Latest News about Market/Moving Exclusives
Recent news which mentions Market/Moving Exclusives
From Benzinga
EXCLUSIVE: SAB Biotherapeutics' Influenza Immunotherapy Shows Safety, Efficacy In Early-Stage Trials
May 04, 2023
From Benzinga
EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial
April 26, 2023
From Benzinga
EXCLUSIVE: Ocean Biomedical's Co-Founder Outlines Detailed Data From Malaria Vaccine At Conference
April 25, 2023
Tickers
OCEA
From Benzinga
EXCLUSIVE: BioRestorative Concludes Enrollment For Safety Run-In Component Of Cell Therapy Study For Chronic Lower Back Pain
April 24, 2023
Tickers
BRTX
From Benzinga
EXCLUSIVE: Ocean Biomedical's Co-Founder Jack Elias To Receive US Patent For Lung Fibrosis Therapeutics
April 20, 2023
Tickers
OCEA
From Benzinga
EXCLUSIVE: Cepton Launches Proprietary Chipset for Automotive Lidar Dubbed "Komodo" To Boost Cloud Quality And Reduce Costs
April 19, 2023
From Benzinga
EXCLUSIVE: SAB Biotherapeutics Secures FDA Breakthrough Therapy Tag For Its Influenza Immunotherapy
April 18, 2023
Tickers
SABS
From Benzinga
EXCLUSIVE: Ocean Biomedical Bags $134M Backing For Innovative Research and IND Fillings
April 17, 2023
Tickers
OCEA
From Benzinga
EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody
April 13, 2023
From Benzinga
EXCLUSIVE: Ocean Biomedical's Co-Founder Expects To Receive US Patent Covering Malaria Therapeutics
April 13, 2023
Tickers
OCEA
From Benzinga
EXCLUSIVE: Tiziana Life Sciences Plans To Develop Multiple Sclerosis Hopeful For Long COVID Patients
April 13, 2023
Tickers
TLSA
From Benzinga
French CAC 40 Index Rockets To New Heights On Luxury Stocks' Wings As US Inflation Rate Slows
April 12, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.